CA2147862A1 - Dispositif de delivrance de medicaments - Google Patents

Dispositif de delivrance de medicaments

Info

Publication number
CA2147862A1
CA2147862A1 CA002147862A CA2147862A CA2147862A1 CA 2147862 A1 CA2147862 A1 CA 2147862A1 CA 002147862 A CA002147862 A CA 002147862A CA 2147862 A CA2147862 A CA 2147862A CA 2147862 A1 CA2147862 A1 CA 2147862A1
Authority
CA
Canada
Prior art keywords
dosage form
medicament
coated
benzopyran
piperidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002147862A
Other languages
English (en)
Inventor
Robert E. Dempski
Robert C. Olivero
Edward C. Scholtz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2147862A1 publication Critical patent/CA2147862A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002147862A 1992-11-05 1993-11-04 Dispositif de delivrance de medicaments Abandoned CA2147862A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97188292A 1992-11-05 1992-11-05
US971,882 1992-11-05

Publications (1)

Publication Number Publication Date
CA2147862A1 true CA2147862A1 (fr) 1994-05-11

Family

ID=25518906

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002147862A Abandoned CA2147862A1 (fr) 1992-11-05 1993-11-04 Dispositif de delivrance de medicaments

Country Status (5)

Country Link
EP (1) EP0668758A1 (fr)
JP (1) JPH08502980A (fr)
AU (1) AU5592694A (fr)
CA (1) CA2147862A1 (fr)
WO (1) WO1994009762A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles
AU2001263506A1 (en) 2000-05-18 2001-11-26 Massachusetts Institute Of Technology Encapsulating a toxic core within a non-toxic region in an oral dosage form
FR2837100B1 (fr) 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
US7906145B2 (en) 2002-04-09 2011-03-15 Flamel Technologies Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
FR2883179B1 (fr) * 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US9877921B2 (en) 2005-09-09 2018-01-30 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
US20160045457A1 (en) 2005-09-09 2016-02-18 Ousama Rachid Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine
FR2920308B1 (fr) * 2007-09-05 2011-02-25 Unither Dev Forme pharmaceutique pour l'administration par voie orale de principes actifs.
US20120322884A1 (en) 2010-03-01 2012-12-20 University Of Manitoba Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
US20140242177A1 (en) 2011-10-21 2014-08-28 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
CA2876883C (fr) 2012-06-15 2022-11-01 Nova Southeastern University Nanoparticules d'epinephrine, procede pour les fabriquer et procedes pour les utiliser pour le traitement d'affections repondant a l'epinephrine
CN103006604B (zh) * 2013-01-16 2014-05-07 苏州中化药品工业有限公司 一种头孢呋辛酯片及其制备方法
CN103110603B (zh) * 2013-01-31 2014-07-02 浙江华立南湖制药有限公司 一种头孢克洛分散片及其制备方法
PT2976072T (pt) 2013-03-22 2021-08-12 Univ Nova Southeastern Partículas finas de epinefrina e métodos de utilização das mesmas para o tratamento de afeções que reagem à epinefrina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082669A (en) * 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
US5215989A (en) * 1989-12-08 1993-06-01 Merck & Co., Inc. Nitrogen-containing heterocyclic compounds as class III antiarrhythmic agents

Also Published As

Publication number Publication date
JPH08502980A (ja) 1996-04-02
AU5592694A (en) 1994-05-24
WO1994009762A1 (fr) 1994-05-11
EP0668758A1 (fr) 1995-08-30

Similar Documents

Publication Publication Date Title
EP3137060B1 (fr) Compositions en suspension à libération prolongée
EP0701437B1 (fr) Systeme de liberation pulsatoire de medicament particulaire
EP0760655B1 (fr) Forme galenique pharmaceutique multicouche a liberation controlee
JP2560019B2 (ja) 活性化合物の放出を制御する新規な製剤およびその製造法
CA2147862A1 (fr) Dispositif de delivrance de medicaments
US8557282B2 (en) Extended release compositions comprising as active compound venlafaxine hydrochloride
US6696091B2 (en) Pharmaceutical composition of topiramate
US4415547A (en) Sustained-release pharmaceutical tablet and process for preparation thereof
US5645858A (en) Multilayered controlled release pharmaceutical dosage form
EP1110553B1 (fr) Preparations orales, a liberation prolongee, a base de chlorhydrate de fasudil
CA2199345A1 (fr) Composition a liberation-retard
NZ556775A (en) Controlled release complex formulation for oral, administration of medicine for diabetes and method for the preparation thereof
BG65306B1 (bg) Лекарствена форма с контролирано освобождаване, съдържаща галантамин
CA2537103A1 (fr) Forme dosifiee quotidienne de trospium
US6482437B2 (en) Morphine sulfate microgranules, manufacturing process and pharmaceutical preparations
KR20010031952A (ko) 카르베디롤을 위한 신규 경구 투여형
KR890004683B1 (ko) 클로로페니라민 제형
US5049374A (en) Oral (coated bead) dosage form for sodium iodide I-131
WO2011027322A1 (fr) Forme galénique à libération prolongée contenant de l'olopatadine pour une administration orale
KR20060065319A (ko) 벤라팍신 염산염을 함유하는 서방성 펠렛
NZ254414A (en) Unit dosage forms comprising pellets containing active agent having various degrees of coating such that the active agent is released sequentially in pulses
SI8710340A8 (en) Process for obtaining novel pharmaceutical composition consisting of layers, which assure controlled release of active compound
HRP920593A2 (en) New drug preparation

Legal Events

Date Code Title Description
FZDE Dead